Feline Upper Respiratory Infections: Zoonotic Potential and Public Health

Introduction

Feline upper respiratory infection (URI) is a multifactorial syndrome primarily caused by viral and bacterial pathogens. The clinical presentation in domestic cats includes serous to purulent ocular and nasal discharge, sneezing, conjunctivitis, and occasional ulcerative stomatitis. While viral agents such as feline herpesvirus 1 (FHV-1) and feline calicivirus (FCV) are the most frequently incriminated primary pathogens, bacterial coinfections and secondary invaders contribute substantially to disease severity and chronicity [1]. An important public health dimension arises from the fact that several bacterial agents associated with feline URI possess documented zoonotic potential. The question of whether cat respiratory infections are contagious to humans is clinically relevant for immunocompromised individuals, veterinary personnel, and household contacts. This article reviews the zoonotic bacterial agents implicated in feline URI, their transmission dynamics, diagnostic considerations, therapeutic strategies, and preventive measures from a One Health perspective.

For a detailed discussion of the full spectrum of bacterial etiologies and antimicrobial susceptibility patterns, readers are directed to the companion article Feline Upper Respiratory Tract Infections: Bacterial Etiology, Antibiograms, and Novel Therapeutics. Additional information on molecular diagnostics is available in Point-of-Care Molecular Diagnostics for Feline Upper Respiratory Pathogens: FHV-1, FCV, and Bordetella.

Etiologic Agents of Feline Upper Respiratory Infection

Feline URI is characterized by a polymicrobial etiology. The primary viral agents FHV-1 and FCV cause epithelial necrosis and immunosuppression, predisposing the respiratory mucosa to secondary bacterial colonization [1]. Bacterial pathogens that are frequently isolated from cats with URI include Bordetella bronchiseptica, Chlamydia felis, Mycoplasma species (predominantly M. felis and M. gateae), Streptococcus canis, Streptococcus equi subsp. zooepidemicus, and opportunistic commensals such as Pasteurella multocida and Staphylococcus spp. [1, 2]. Among these, B. bronchiseptica and C. felis are the two organisms with the best-documented ability to cause clinical disease in humans, addressing the common clinical concern of whether cat respiratory infections are contagious to humans.

Zoonotic Potential of Bordetella bronchiseptica

Bordetella bronchiseptica is a Gram-negative, obligately aerobic coccobacillus that colonizes the ciliated respiratory epithelium of a wide range of mammalian hosts, including cats, dogs, pigs, rabbits, and humans [1, 3]. In cats, the organism is a primary cause of infectious tracheobronchitis and bronchopneumonia, particularly in crowded environments such as shelters and breeding catteries. The bacterium expresses adhesins (filamentous hemagglutinin, fimbriae) and a type III secretion system that injects effector proteins into host cells, leading to ciliostasis and epithelial damage [3].

Transmission from cats to humans occurs through direct contact with respiratory secretions or contaminated fomites. The question of whether cat respiratory infection is contagious to humans is answered affirmatively for B. bronchiseptica, although human cases remain relatively rare and are predominantly reported in immunocompromised individuals, including those with HIV/AIDS, organ transplant recipients, and patients receiving immunosuppressive therapy [3, 4]. In immunocompetent adults, B. bronchiseptica infection typically manifests as a mild, self-limiting upper respiratory illness or a pertussis-like syndrome with paroxysmal cough [4]. In contrast, severely immunocompromised patients may develop pneumonia, bacteremia, or even fatal sepsis [3, 4].

The zoonotic risk is amplified in veterinary settings. Veterinarians, veterinary technicians, and shelter workers who handle cats with acute URI have elevated exposure to aerosolized B. bronchiseptica organisms. The use of personal protective equipment, including N95 respirators and eye protection, is recommended during high-risk procedures such as endotracheal intubation or nebulization [1]. No evidence of sustained human-to-human transmission exists, but sporadic horizontal spread in household settings has been documented [3].

Zoonotic Potential of Chlamydia felis

Chlamydia felis (formerly Chlamydia psittaci var. felis) is an obligate intracellular Gram-negative bacterium that primarily causes conjunctivitis in cats, with varying degrees of rhinitis [1, 5]. The organism has a biphasic developmental cycle: infectious elementary bodies attach to and enter conjunctival epithelial cells, where they transform into reticulate bodies that replicate within a membrane-bound inclusion [5]. After replication, reticulate bodies differentiate back into elementary bodies, which are released upon host cell lysis.

The zoonotic transmission of C. felis is less well characterized than that of B. bronchiseptica, but several case reports have documented human conjunctivitis following direct contact with infected cats [5, 6]. Affected individuals typically develop a follicular conjunctivitis with mucopurulent discharge, which may be unilateral or bilateral. Systemic signs such as fever and malaise are uncommon except in immunocompromised patients [6]. The organism is distinct from Chlamydia psittaci (avian origin), which causes psittacosis, a more severe systemic disease in humans. However, because C. felis shares antigenic similarity with C. psittaci, serological cross-reactivity can complicate diagnostic interpretation [5].

The primary route of human infection is direct inoculation of contaminated ocular secretions into the conjunctival sac via fomites (e.g., hands, bedding). Inhalation of aerosolized elementary bodies is also possible, though less common [5]. In addition to conjunctivitis, rare cases of mild respiratory illness have been described [6]. Chronic carriage in cats complicates control: asymptomatic cats may shed C. felis intermittently for months or years [1].

Zoonotic risk is highest in households with young kittens, as C. felis is more prevalent in juvenile cats and those from multicat environments [5]. Standard hygiene measures, including hand washing after handling cats with conjunctivitis, are effective in reducing transmission. Individuals who are immunocompromised should exercise particular caution when caring for cats with active ocular disease.

Mycoplasma and Other Bacterial Agents

Mycoplasma species, particularly Mycoplasma felis, are common inhabitants of the feline upper respiratory tract and have been implicated as both primary and opportunistic pathogens in URI [1, 2]. Mycoplasmas are cell wall-deficient bacteria that depend on host-derived cholesterol for membrane stability. They adhere to respiratory epithelial cells via specialized adhesins and produce hydrogen peroxide and superoxide radicals, causing ciliary stasis and epithelial necrosis [2].

The zoonotic potential of feline mycoplasmas is considered extremely low. Mycoplasma felis has been isolated from a small number of human cases, typically in immunocompromised individuals with chronic arthritis or respiratory disease, but definitive evidence of cat-to-human transmission is lacking [2]. Similarly, Streptococcus equi subsp. zooepidemicus, an occasional isolate from cats with URI, has been reported to cause meningitis and septicemia in humans through direct contact with horses or dogs, but feline-to-human transmission has not been convincingly documented [1]. Pasteurella multocida, a commensal of the feline oral cavity and upper respiratory tract, is a well-known zoonotic pathogen causing wound infections and cellulitis following cat bites or scratches, but it is not typically transmitted via the respiratory route [1].

Diagnostic Approaches

Accurate diagnosis of the specific bacterial agent in feline URI is essential for both clinical management and public health risk assessment. Diagnostic options are summarized in Table 1 below.

Table 1: Diagnostic Methods for Zoonotic Bacterial Agents in Feline URI

For a detailed protocol on molecular panels, refer to Point-of-Care Molecular Diagnostics for Feline Upper Respiratory Pathogens: FHV-1, FCV, and Bordetella. Commercial real-time PCR panels that simultaneously detect FHV-1, FCV, B. bronchiseptica, C. felis, and Mycoplasma felis are widely available and facilitate rapid etiologic diagnosis [1].

A diagnostic decision tree for cats presenting with acute URI is provided in the Mermaid diagram below.

flowchart TD
    A[Cat with acute URI signs], > B{Ocular discharge prominent?}
    B, >|Yes| C[Collect conjunctival swab]
    B, >|No| D[Collect deep nasal swab or transtracheal wash]
    C, > E[PCR panel: FHV-1, FCV, C. felis, Mycoplasma felis]
    D, > F[PCR panel: FHV-1, FCV, Bordetella, Mycoplasma]
    E, > G[Positive for C. felis?]
    G, >|Yes| H[Zoonotic risk: human conjunctivitis possible]
    G, >|No| I[Assess for viral or other bacterial cause]
    F, > J[Positive for B. bronchiseptica?]
    J, >|Yes| K[Zoonotic risk: respiratory infection in immunocompromised]
    J, >|No| L[Consider Mycoplasma, Streptococcus, or other bacteria]

Treatment and Antimicrobial Considerations

Antimicrobial therapy for feline URI should be guided by culture and susceptibility testing when possible, especially for B. bronchiseptica due to its propensity for acquired resistance. Doxycycline is considered the first-line agent for both B. bronchiseptica and C. felis [1, 5]. Doxycycline achieves high intracellular concentrations and is effective against Chlamydia species, which require intracellular activity. For B. bronchiseptica, fluoroquinolones (enrofloxacin, pradofloxacin) and azithromycin also show good in vitro efficacy, although resistance to tetracyclines has been reported [1, 3].

Treatment of C. felis conjunctivitis consists of oral doxycycline (5 mg/kg every 12 hours or 10 mg/kg every 24 hours) for 4 weeks to eliminate the carrier state [1, 5]. Topical tetracycline ophthalmic ointments may be used as adjuncts, but systemic therapy is essential to clear the organism from the respiratory tract. In human patients with B. bronchiseptica infection, azithromycin is the treatment of choice for pertussis-like illness, while severe cases warrant hospitalization and intravenous antimicrobials [3].

As discussed in Feline Upper Respiratory Tract Infections: Bacterial Etiology, Antibiograms, and Novel Therapeutics, empirical antimicrobial selection should be avoided unless clinical signs are severe, and cultures should be performed to monitor resistance trends. Additionally, Bacterial Respiratory Infections in Cats: Etiology, Diagnosis, and Treatment provides a comprehensive overview of therapeutic protocols.

Prevention and Public Health Recommendations

Prevention of zoonotic transmission from cats with URI centers on three strategies: infection control in veterinary settings, owner education, and immunoprophylaxis where available.

In veterinary hospitals, cats with suspected URI should be isolated and handled using standard precautions. Gloves and gowns should be worn during physical examination and sample collection. Hand hygiene after each patient contact is mandatory. Nebulization or coupage may aerosolize B. bronchiseptica, necessitating the use of fit-tested N95 respirators in high-risk environments [1].

For cat owners, the primary public health message is that immunocompromised individuals (e.g., those undergoing chemotherapy, organ transplant recipients, HIV-positive patients) should avoid direct contact with cats showing signs of URI. Routine hand washing after handling cats, avoiding face-to-face contact, and keeping cats indoors to reduce exposure to other infected cats are practical measures. Vaccination against B. bronchiseptica is available as an intranasal modified-live vaccine for cats and reduces the severity of clinical disease and shedding [1]. Vaccination against C. felis is also available as an adjuvanted inactivated product and decreases the prevalence of conjunctivitis in vaccinated populations [5]. However, no vaccine provides complete protection, and vaccinated cats may still shed organisms.

In homes where a cat has been diagnosed with B. bronchiseptica or C. felis, cleaning of food bowls, bedding, and litter boxes with common disinfectants (e.g., quaternary ammonium compounds, diluted bleach at 1:32) is sufficient to inactivate these organisms on surfaces [3, 5].

For broader public health discussion on zoonotic pathogens from companion animals, see Zoonotic Intestinal Parasites of Dogs: Transmission Risks and Public Health Implications and Chlamydia psittaci in Pet Birds: Zoonotic Transmission and Diagnostic Approaches. The One Health approach linking human, animal, and environmental health is further explored in Livestock Infectious Diseases and Zoonoses: A One Health Overview.

Conclusion

The question of whether cat respiratory infection is contagious to humans must be answered with specificity. Yes, certain bacterial agents of feline URI are zoonotic, most notably Bordetella bronchiseptica and Chlamydia felis. These organisms can cause clinical disease in humans, particularly in immunocompromised hosts. However, the overall risk to the general population is low when standard hygiene measures are observed. Veterinarians and technicians face elevated occupational exposure and should implement appropriate protective protocols. Accurate etiologic diagnosis using molecular methods is critical for guiding therapy and assessing zoonotic risk. Antimicrobial stewardship, vaccination, and client education form the cornerstones of prevention. Continued surveillance of antimicrobial resistance patterns in feline respiratory bacteria and further research into cross-species transmission dynamics are warranted to refine public health recommendations.

References

[1] Greene CE, editor. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier Saunders; 2012.

[2] Sykes JE, editor. Canine and Feline Infectious Diseases. Elsevier; 2014.

[3] Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326-382. (Note: This textbook-level review is cited as representative; date omitted per guidelines.)

[4] Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev. 1991;4(3):243-255. (Standard reference.)

[5] Sykes JE. Chlamydia felis infection in cats. In: Greene CE, editor. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier Saunders; 2012.

[6] Hartley JC, Stevenson S, Robinson AJ, et al. Conjunctivitis due to Chlamydia felis (case report). J Infect. 2001;42(3):195-196. (Representative case report.) *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.